Authors:
RINEHART J
HERSH E
ISSELL B
TRIOZZI P
BUHLES W
NEIDHART J
Citation: J. Rinehart et al., PHASE-1 TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA (RHIL-1-BETA), CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH SOLID CANCERS - SOUTHWEST-ONCOLOGY-GROUP STUDY 8940, Cancer investigation, 15(5), 1997, pp. 403-410
Authors:
SPECTOR SA
MCKINLEY GF
LALEZARI JP
SAMO T
ANDRUCZK R
FOLLANSBEE S
SPARTI PD
HAVLIR DV
SIMPSON G
BUHLES W
WONG R
STEMPIEN MJ
Citation: Sa. Spector et al., ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN PERSONS WITH AIDS, The New England journal of medicine, 334(23), 1996, pp. 1491-1497
Authors:
YUEN GJ
DRUSANO GL
FLETCHER C
CAPPARELLI E
CONNOR JD
LALEZARI JP
DREW L
FOLLANSBEE S
BUSCH D
JACOBSON M
SPECTOR SA
SQUIRES K
BUHLES W
Citation: Gj. Yuen et al., POPULATION DIFFERENCES IN GANCICLOVIR CLEARANCE AS DETERMINED BY NONLINEAR MIXED-EFFECTS MODELING, Antimicrobial agents and chemotherapy, 39(10), 1995, pp. 2350-2352
Authors:
DREW WL
IVES D
LALEZARI JP
CRUMPACKER C
FOLLANSBEE SE
SPECTOR SA
BENSON CA
FRIEDBERG DN
HUBBARD L
STEMPIEN MJ
SHADMAN A
BUHLES W
Citation: Wl. Drew et al., ORAL GANCICLOVIR AS MAINTENANCE TREATMENT FOR CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS, The New England journal of medicine, 333(10), 1995, pp. 615-620
Authors:
SPECTOR SA
BUSCH DF
FOLLANSBEE S
SQUIRES K
LALEZARI JP
JACOBSON MA
CONNOR JD
JUNG D
SHADMAN A
MASTRE B
BUHLES W
DREW WL
DANKNER WM
MEIXNER L
FREEMAN WR
DYNER TS
FREEMAN E
MORTILLARO G
GLUTZER E
BUSH T
COLEMAN R
Citation: Sa. Spector et al., PHARMACOKINETIC, SAFETY, AND ANTIVIRAL PROFILES OF ORAL GANCICLOVIR IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - A PHASE I II STUDY/, The Journal of infectious diseases, 171(6), 1995, pp. 1431-1437
Authors:
PLAISANCE K
PISCITELLI DA
YOUNG D
BIGORA S
PERDUE B
KEAY S
GAINES K
JUNG D
BUHLES W
Citation: K. Plaisance et al., EXPOSURE PARAMETERS AND OUTCOME OF CMV RETINITIS FOR ORAL GANCICLOVIR, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 177-177
Authors:
PISCITELLI DA
PLAISANCE K
YOUNG D
BIGORA S
PERDUE B
GAINES K
JUNG D
BUHLES W
Citation: Da. Piscitelli et al., NONLINEAR MIXED EFFECTS MODELING (NONMEM) OF THE POPULATION PHARMACOKINETICS (PPK) OF ORAL GANCICLOVIR (GA), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 214-214
Authors:
NEMUNAITIS J
ROSS M
MEISENBERG B
APPELBAUM FR
BUHLES W
SINGER J
PETERS WP
OREILLY R
LILLEBY K
BUCKNER CD
Citation: J. Nemunaitis et al., PHASE-I STUDY OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA (RHIL-1-BETA) IN PATIENTS WITH BONE-MARROW FAILURE, Bone marrow transplantation, 14(4), 1994, pp. 583-588
Authors:
SPECTOR SA
WEINGEIST T
POLLARD RB
DIETERICH DT
SAMO T
BENSON CA
BUSCH DF
FREEMAN WR
MONTAGUE P
KAPLAN HJ
KELLERMAN L
CRAGER M
DEARMOND B
BUHLES W
FEINBERG J
Citation: Sa. Spector et al., A RANDOMIZED, CONTROLLED-STUDY OF INTRAVENOUS GANCICLOVIR THERAPY FORCYTOMEGALOVIRUS PERIPHERAL RETINITIS IN PATIENTS WITH AIDS, The Journal of infectious diseases, 168(3), 1993, pp. 557-563